Hanmi to release generic Nexium in U.S. market shortly

Published: 2013-06-07 07:00:00

Updated: 2013-06-07 07:00:00

Hanmi Pharmaceutical Co. on Tuesday announced that based on a confidential settlement agreement, a consent judgment has been entered by the United States District Court for the District of New Jersey with respect to the ongoing patent infringement litigation between Hanmi and AstraZeneca involvin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK